AlphaMaven

Company Logo'

Venture Capital

Ripple VC Africa Fund I

Ripple VC
Invest in companies using science and advanced technology to solve trillion-dollar problems
Request More Information

Investment Overview

Strategy Description

Ripple VC is on a mission to propel Africa to the forefront of innovation by backing entrepreneurs using science and advanced technology to solve trillion-dollar problems. Ripple VC provides seed capital and focuses energies on helping with Fortune 500 relationships to expand market opportunities and scale product-market fit. Join us. Investor presentation: https://docsend.com/view/fd5yi7uukpcx4dhy
Principals

Osayi Igharo
Osayi Igharo - Managing Partner, Ripple VC
Investment Highlights

Investment Category

Venture Capital

Investment Strategy

Emerging Market, Early Stage, Venture Capital, Disruptive Technologies, Africa, Science, Deep Tech

Investment Structure

Fund, Delaware LP

Objective

Our Performance Goal
Target 5x+ net return (DPI)

Investment Opportunity

What We Believe
With record-breaking fundraising activity and exits, Africa presents investors with an attractive opportunity to invest for returns & impact at scale.

Return Driver - Alpha

Our Edge
Experience, Deal Sourcing Network, Differentiated Thinking, Repeatable Process, Management Capability, Market Timing, Purpose-driven, Concentrated
Implementation of Strategy
Tactical Approach

Market Sector Exposure

Healthcare, Aerospace, Biotech, Cybersecurity, Autonomous Manufacturing, Agriculture

Capitalization Weight

Early Stage

Geographical Exposure

Africa

Average Timeframe

Fund Life - 10 Years

Risk Management

Diversification, Position Limits, Liquidity Requirements, Systematic Processes, Active management, Due Diligence Process
Investment Structure

Legal Structure

Limited Partnership

Domicile

United States

Fund Minimum Investment

$100K

Management Fee (%)

2%

Incentive Fee (%)

20%
Service Providers

Administrator

AngelList

Legal

Ross Law Group
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.
You May Also Enjoy The Following Posts
Andrea Alms Video:  Money In Motion 101 - Deep Dive - Immunotherapy Cancer Market
2w ago PrivateEquity BrookDell Partners
Andrea Alms Video:  Money In Motion 96 - Bone Marrow Transplantation Market
1mo ago PrivateEquity BrookDell Partners
Ridgedale MSP Partner Series - March 2024 Newsletter
1w ago HedgeFund Ridgedale MSP Partner Series
Andrea Alms Video:  Money In Motion 100 - Cancer Market Wrap-Up
3w ago PrivateEquity BrookDell Partners
Andrea Alms Video:  Money In Motion 102 - Deep Dive Immunotherapy Cancer Market Part 3
2w ago PrivateEquity BrookDell Partners
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.